(Q33254071)

24 July 2017

Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system (English)

1 reference

24 July 2017

1 reference

1 reference

head and neck carcinoma

1 reference

7

Michael Flentje

1 reference

24 July 2017

Dirk Vordermark

1

1 reference

24 July 2017

Harun M Said

2

1 reference

24 July 2017

Astrid Katzer

3

1 reference

24 July 2017

Thomas Kuhnt

4

1 reference

24 July 2017

Gabriele Hänsgen

5

1 reference

24 July 2017

Jürgen Dunst

6

1 reference

24 July 2017

Matthias Bache

8

1 reference

24 July 2017

language of work or name

English

0 references

publication date

15 August 2006

1 reference

24 July 2017

1 reference

24 July 2017

6

1 reference

24 July 2017

207

1 reference

Creative Commons Attribution 2.0 Generic

24 July 2017

start time

15 August 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2407-6-207

0 references

cites work

Influence of oxygen concentration and pH on expression of hypoxia induced genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Serum protein markers for early detection of ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Role of osteopontin in tumour progression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Osteopontin: a protein with diverse functions.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1564036

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-207

Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-207

Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-207

Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-207

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-207

Elevated osteopontin levels in active relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-207

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-207

Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-207

Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma

21 January 2018

1 reference

12 December 2020

Plasma osteopontin levels are associated with the presence and extent of coronary artery disease

1 reference

12 December 2020

Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers

1 reference

12 December 2020

Asbestos exposure, pleural mesothelioma, and serum osteopontin levels

1 reference

12 December 2020

Serum osteopontin levels in patients with acute liver dysfunction

1 reference

12 December 2020

Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms

1 reference

12 December 2020

High plasma concentrations of osteopontin in patients with interstitial pneumonia

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-6-207

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference

24 July 2017

1 reference